| [1] | Lixian WU, Weiqiang ZHENG, Huanqin HAN. Effect of different antiviral drugs in reducing the risk of hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(5): 1165-1168. doi: 10.3969/j.issn.1001-5256.2022.05.040 |
| [2] | Mingyang FENG, Hui WANG. Selection of antiviral drugs for patients with hepatitis B virus-associated hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2452-2456. doi: 10.3969/j.issn.1001-5256.2022.11.004 |
| [3] | Aoxue CUI, Xiaoguang DOU, Yang DING. Antiviral therapy for pregnant women and children with chronic HBV infection[J]. Journal of Clinical Hepatology, 2022, 38(11): 2448-2451. doi: 10.3969/j.issn.1001-5256.2022.11.003 |
| [4] | Pan ZHAO, Yi DONG, Jiaqi LIU, Xue GAO, Yiwei WU, Shishu ZHU, Limin WANG, Zhenman WEI. Clinical follow-up of children with immune-tolerant chronic hepatitis B receiving antiviral therapy[J]. Journal of Clinical Hepatology, 2021, 37(7): 1558-1560. doi: 10.3969/j.issn.1001-5256.2021.07.016 |
| [5] | Limin WANG, Shuhong LIU, Shishu ZHU, Yi DONG, Zhiqiang XU, Fuchuan WANG, Jianguo YAN, Pu WANG, Aiqin LI, Lili CAO, Pan ZHAO, Min ZHANG. Association of the expression of HBsAg and HBcAg in liver tissue with antiviral response in children with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(1): 46-50. doi: 10.3969/j.issn.1001-5256.2021.01.010 |
| [6] | Zhang JieBing, Guo HongHua. Research advances in hepatitis B cirrhosis with renal injury and the application of antiviral drugs[J]. Journal of Clinical Hepatology, 2019, 35(1): 191-196. doi: 10.3969/j.issn.1001-5256.2019.01.042 |
| [7] | Ning HuiBin, Liu JunPing, Jin HuiMing, Li Kuan, Xiao ErHui, Shang Jia. Direct-acting antiviral durgs for hepatitis C in children: A case report[J]. Journal of Clinical Hepatology, 2019, 35(1): 164-165. doi: 10.3969/j.issn.1001-5256.2019.01.032 |
| [8] | Wang MengLan, Tang Hong. Drug-drug interaction of direct-acting antivirals in treatment of chronic hepatitis C[J]. Journal of Clinical Hepatology, 2018, 34(2): 229-232. doi: 10.3969/j.issn.1001-5256.2018.02.002 |
| [9] | Zhang Xi, Li YongGuo. Current status of the application of direct-acting antiviral agents in treatment of chronic hepatitis C and existing problems[J]. Journal of Clinical Hepatology, 2018, 34(4): 853-857. doi: 10.3969/j.issn.1001-5256.2018.04.034 |
| [10] | Nan YueMin, Li DongDong, Kong LingBo. Focus on the treatment of chronic hepatitis C in children[J]. Journal of Clinical Hepatology, 2018, 34(2): 246-250. doi: 10.3969/j.issn.1001-5256.2018.02.006 |
| [11] | Chen XinYue, Liu YaLi, Ren Shan. Value of direct-acting antivirals combined with PR regimen (PEG-IFN combined with ribavirin) in the new era of antiviral therapy for hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(6): 1063-1066. doi: 10.3969/j.issn.1001-5256.2017.06.009 |
| [12] | Bian DanDan, Zheng SuJun. Influencing factors for the therapeutic effect of direct-acting antiviral agents in hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(11): 2205-2208. doi: 10.3969/j.issn.1001-5256.2017.11.034 |
| [13] | Ceng Qun, Jie ShengHua. Research advances in antiviral drugs and their treatment regimens in chronic hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(11): 2200-2204. doi: 10.3969/j.issn.1001-5256.2017.11.033 |
| [14] | Wen XiaoYu, Niu JunQi. Mechanism of action of direct-acting antiviral agents in treatment of chronic hepatitis C[J]. Journal of Clinical Hepatology, 2016, 32(9): 1699-1705. doi: 10.3969/j.issn.1001-5256.2016.09.013 |
| [15] | Zhang Jing, Liu XueMin, Liu ZhengWen, Lu: Yi. Application of direct-acting antiviral agents in perioperative period of liver transplantation for patients with hepatitis C[J]. Journal of Clinical Hepatology, 2015, 31(12): 2084-2087. doi: 10.3969/j.issn.1001-5256.2015.12.023 |
| [16] | Ren Shan, Chen XinYue. Current research on hepatitis C virus resistance to direct-acting antiviral agents[J]. Journal of Clinical Hepatology, 2015, 31(11): 1807-1812. doi: 10.3969/j.issn.1001-5256.2015.11.010 |
| [17] | Zhu ShiShu, Zhang HongFei. Antiviral therapy of chronic hepatitis B in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1211-1214. doi: 10.3969/j.issn.1001-5256.2015.08.007 |
| [18] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
| [19] | Xie ZhengDe. Relationship between Epstein-Barr virus infection and hepatic lesions in children[J]. Journal of Clinical Hepatology, 2012, 28(12): 893-895. |
| [20] | Wen ZhongXiang, Zhu Peng, Wang YuMing. Recent progress in clinical research of hepatitis C virus infection in pediatric patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 888-892. |
DownLoad: